cardiovascular disease
| 8 min read
As nearly 90 percent of drugs fail in human trials, researchers are turning to patient-derived cells, engineered tissues, and AI to better predict human responses and reduce costly late-stage failures.
| 3 min read
A gene therapy targeting ANTIGPTL3 reduced cholesterol and triglyceride levels simultaneously.
| 4 min read
| 7 min read
With blockbuster status secured, GLP-1 therapies face new questions about efficacy, delivery, and their role in treating multiple chronic diseases.
| 3 min read
Immune cells carried an antioxidant to a mouse’s cardiac muscle cells, which had been damaged by a heart attack.
| 10+ min read
After a heart attack, the damage is permanent — for now. Researchers are testing innovative ways to get the heart to regenerate muscle cells and fix itself.
| 3 min read
Researchers revealed a connection between age-related Y chromosome gene loss and increased heart scarring in men.
| 6 min read
Researchers harvest stem cells from patients who have recently had a heart attack and use them to trigger regeneration of their cardiac muscle.
| 5 min read
Researchers developed a nanopore platform that detects a range of biomarkers at the same time, paving the way for more precise liquid biopsies.
| 3 min read
As an alternative to daily pills, a new RNAi drug could lower blood pressure with a twice-yearly injection.
